|
Checkpoint Inhibitor–Associated Diabetes: Risk Prediction, Clinical Phenotypes, and Emerging Mechanisms SIG Webinar
Date(s):
April 29, 2026
Venue:Virtual Meeting
Your Location
Online Access
Website:https://www.endocrine.org/our-community/special-interest-groups/oncoendocrinology
Fee(s):This event has a fee
Description:Checkpoint inhibitor–associated diabetes (CIADM) is an increasingly recognized immune-related adverse event. This webinar will review approaches to risk prediction and pre-treatment screening, strategies to distinguish CIADM from other causes of hyperglycemia, and emerging insights into underlying immunologic mechanisms, with a focus on implications for future prevention and patient care.
Learning Objectives
- Identify patients at increased risk for checkpoint inhibitor–associated diabetes (CIADM) and apply strategies for pre-treatment screening and risk stratification.
- Differentiate clinical phenotypes of CIADM from other causes of hyperglycemia in patients receiving checkpoint inhibitors, using key clinical and laboratory features.
...
|
Sessions information is not available at this time.
|
|
Track information is not available at this time.
|
|
Wu, Linda
Organization: University of Sydney
|
|
Sponsor information is not available at this time.
|
|
|
|